Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.88B
Enterprise Value2.79B
P/E Ratio109.09
PEG Ratio-9.92
Price/Sales Ratio4.48
Price/Book Ratio4.52
Enterprise/Revenue4.42
Enterprise/EBITDA30.68

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue877.85M
Revenue/Share2.38
Gross Profit584.11M
EBITDA126.91M
Net Income43.95M
Diluted EPS0.14

Balance Sheet

Total Cash169.22M
Total Cash/Share0.56
Total Debt123.62M
Total Debt/Equity0.17
Current Ratio1.65
Book Value Per Share2.8

Price History

52-Week Change5.01
52-Week High20.96
52-Week Low6.78
Moving Average 50 Days14.03
Moving Average 200 Days10.76

Statistics

Average Volume64.49M
Shares Outstanding303.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.37
Payout Ratio0.05
Last Split Factor7:2
Last Split DateMay 10, 2017
AD